Astrocytes as a regulated source of retinoic acid for the brain

Kirsty D Shearer, Yara D Fragoso, Margaret Clagett-Dame, Peter J McCaffery

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Retinaldehyde dehydrogenases (RALDH) catalyze the synthesis of the regulatory factor retinoic acid (RA). Cultured astrocytes express several of the RALDH enzyme family, and it has been assumed that this can be extrapolated to astrocytes in vivo. However, this study finds that few astrocytes in the rodent brain express detectable RALDH enzymes, and only when these cells are grown in culture are these enzymes upregulated. Factors controlling the expression of the RALDHs in cultured astrocytes were explored to determine possible reasons for differences between in vitro versus in vivo expression. Retinoids were found to feedback to suppress several of the RALDHs, and physiological levels of retinoids may be one route by which astrocytic RALDHs are maintained at low levels. In the case of RALDH2, in vivo reduction of vitamin A levels in rats resulted in an increase in astrocyte RALDH2 expression in the hippocampus. Other factors though are likely to control RALDH expression. A shift in astrocytic RALDH subcellular localization is a potential mechanism for regulating RA signaling. Under conditions of vitamin A deficiency, RALDH2 protein moved from the cytoplasm to the nucleus where it may synthesize RA at the site of the nuclear RA receptors. Similarly, in conditions of oxidative stress RALDH1 and RALDH2 moved from the cytoplasm to a predominantly nuclear position. Thus, the RALDHs have been revealed to be dynamic in their expression in astrocytes where they may maintain retinoid homeostasis in the brain. © 2012 Wiley Periodicals, Inc.
Original languageEnglish
Pages (from-to)1964-1976
Number of pages13
JournalGlia
Volume60
Issue number12
Early online date28 Aug 2012
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Retinaldehyde
Tretinoin
Astrocytes
Oxidoreductases
Retinoids
Brain
Cytoplasm
Enzymes
Vitamin A Deficiency
Retinoic Acid Receptors
Vitamin A
Rodentia
Hippocampus
Oxidative Stress
Homeostasis
Proteins

Keywords

  • retinaldehyde dehydrogenase
  • retinol
  • vitamin A deficiency
  • nuclear translocation

Cite this

Astrocytes as a regulated source of retinoic acid for the brain. / Shearer, Kirsty D; Fragoso, Yara D; Clagett-Dame, Margaret; McCaffery, Peter J.

In: Glia, Vol. 60, No. 12, 12.2012, p. 1964-1976.

Research output: Contribution to journalArticle

Shearer, Kirsty D ; Fragoso, Yara D ; Clagett-Dame, Margaret ; McCaffery, Peter J. / Astrocytes as a regulated source of retinoic acid for the brain. In: Glia. 2012 ; Vol. 60, No. 12. pp. 1964-1976.
@article{04d8bcb0e726420185221fb317040d19,
title = "Astrocytes as a regulated source of retinoic acid for the brain",
abstract = "Retinaldehyde dehydrogenases (RALDH) catalyze the synthesis of the regulatory factor retinoic acid (RA). Cultured astrocytes express several of the RALDH enzyme family, and it has been assumed that this can be extrapolated to astrocytes in vivo. However, this study finds that few astrocytes in the rodent brain express detectable RALDH enzymes, and only when these cells are grown in culture are these enzymes upregulated. Factors controlling the expression of the RALDHs in cultured astrocytes were explored to determine possible reasons for differences between in vitro versus in vivo expression. Retinoids were found to feedback to suppress several of the RALDHs, and physiological levels of retinoids may be one route by which astrocytic RALDHs are maintained at low levels. In the case of RALDH2, in vivo reduction of vitamin A levels in rats resulted in an increase in astrocyte RALDH2 expression in the hippocampus. Other factors though are likely to control RALDH expression. A shift in astrocytic RALDH subcellular localization is a potential mechanism for regulating RA signaling. Under conditions of vitamin A deficiency, RALDH2 protein moved from the cytoplasm to the nucleus where it may synthesize RA at the site of the nuclear RA receptors. Similarly, in conditions of oxidative stress RALDH1 and RALDH2 moved from the cytoplasm to a predominantly nuclear position. Thus, the RALDHs have been revealed to be dynamic in their expression in astrocytes where they may maintain retinoid homeostasis in the brain. {\circledC} 2012 Wiley Periodicals, Inc.",
keywords = "retinaldehyde dehydrogenase, retinol, vitamin A deficiency, nuclear translocation",
author = "Shearer, {Kirsty D} and Fragoso, {Yara D} and Margaret Clagett-Dame and McCaffery, {Peter J}",
note = "Copyright {\circledC} 2012 Wiley Periodicals, Inc.",
year = "2012",
month = "12",
doi = "10.1002/glia.22412",
language = "English",
volume = "60",
pages = "1964--1976",
journal = "Glia",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Astrocytes as a regulated source of retinoic acid for the brain

AU - Shearer, Kirsty D

AU - Fragoso, Yara D

AU - Clagett-Dame, Margaret

AU - McCaffery, Peter J

N1 - Copyright © 2012 Wiley Periodicals, Inc.

PY - 2012/12

Y1 - 2012/12

N2 - Retinaldehyde dehydrogenases (RALDH) catalyze the synthesis of the regulatory factor retinoic acid (RA). Cultured astrocytes express several of the RALDH enzyme family, and it has been assumed that this can be extrapolated to astrocytes in vivo. However, this study finds that few astrocytes in the rodent brain express detectable RALDH enzymes, and only when these cells are grown in culture are these enzymes upregulated. Factors controlling the expression of the RALDHs in cultured astrocytes were explored to determine possible reasons for differences between in vitro versus in vivo expression. Retinoids were found to feedback to suppress several of the RALDHs, and physiological levels of retinoids may be one route by which astrocytic RALDHs are maintained at low levels. In the case of RALDH2, in vivo reduction of vitamin A levels in rats resulted in an increase in astrocyte RALDH2 expression in the hippocampus. Other factors though are likely to control RALDH expression. A shift in astrocytic RALDH subcellular localization is a potential mechanism for regulating RA signaling. Under conditions of vitamin A deficiency, RALDH2 protein moved from the cytoplasm to the nucleus where it may synthesize RA at the site of the nuclear RA receptors. Similarly, in conditions of oxidative stress RALDH1 and RALDH2 moved from the cytoplasm to a predominantly nuclear position. Thus, the RALDHs have been revealed to be dynamic in their expression in astrocytes where they may maintain retinoid homeostasis in the brain. © 2012 Wiley Periodicals, Inc.

AB - Retinaldehyde dehydrogenases (RALDH) catalyze the synthesis of the regulatory factor retinoic acid (RA). Cultured astrocytes express several of the RALDH enzyme family, and it has been assumed that this can be extrapolated to astrocytes in vivo. However, this study finds that few astrocytes in the rodent brain express detectable RALDH enzymes, and only when these cells are grown in culture are these enzymes upregulated. Factors controlling the expression of the RALDHs in cultured astrocytes were explored to determine possible reasons for differences between in vitro versus in vivo expression. Retinoids were found to feedback to suppress several of the RALDHs, and physiological levels of retinoids may be one route by which astrocytic RALDHs are maintained at low levels. In the case of RALDH2, in vivo reduction of vitamin A levels in rats resulted in an increase in astrocyte RALDH2 expression in the hippocampus. Other factors though are likely to control RALDH expression. A shift in astrocytic RALDH subcellular localization is a potential mechanism for regulating RA signaling. Under conditions of vitamin A deficiency, RALDH2 protein moved from the cytoplasm to the nucleus where it may synthesize RA at the site of the nuclear RA receptors. Similarly, in conditions of oxidative stress RALDH1 and RALDH2 moved from the cytoplasm to a predominantly nuclear position. Thus, the RALDHs have been revealed to be dynamic in their expression in astrocytes where they may maintain retinoid homeostasis in the brain. © 2012 Wiley Periodicals, Inc.

KW - retinaldehyde dehydrogenase

KW - retinol

KW - vitamin A deficiency

KW - nuclear translocation

U2 - 10.1002/glia.22412

DO - 10.1002/glia.22412

M3 - Article

C2 - 22930583

VL - 60

SP - 1964

EP - 1976

JO - Glia

JF - Glia

SN - 0894-1491

IS - 12

ER -